Stem cells as tools for studying the genetics of inherited retinal degenerations

Cold Spring Harbor Perspectives in Medicine

Volumn 5, Issue 5, 2015, Pages

  Wiley, Luke A ^a   Burnight, Erin R ^a   Mullins, Robert F ^a   Stone, Edwin M ^a,b   Tucker, Budd A ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE RELATED MACULAR DEGENERATION; ARTICLE; DISEASE PREDISPOSITION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; PATHOPHYSIOLOGY; PLURIPOTENT STEM CELL; RETINA DEGENERATION; RETINITIS PIGMENTOSA; STARGARDT DISEASE; STEM CELL; STEM CELL TRANSPLANTATION; VITELLIFORM MACULAR DEGENERATION; BIOLOGICAL THERAPY; GENE THERAPY; GENETICS; MUTATION; QUALITY OF LIFE; RETINAL DEGENERATION; TRANSPLANTATION;

CELL- AND TISSUE-BASED THERAPY; GENETIC THERAPY; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MUTATION; QUALITY OF LIFE; RETINAL DEGENERATION;

EID: 84930505333     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a017160     Document Type: Article

References (60)

1. Abramoff MD, Mullins RF, Lee K, Hoffmann JM, Sonka M, Critser DB, Stasheff SF, Stone EM. 2013. Human photo-receptor outer segments shorten during light adaptation. Invest Ophthalmol Vis Sci 54: 3721-3728
2. Agosta E, Lazzeri S, Orlandi P, Figus M, Fioravanti A, Di Desidero T, Sartini MS, Nardi M, Danesi R, Bocci G. 2012. Pharmacogenetics of antiangiogenic and antineo- vascular therapies of age-related macular degeneration. Pharmacogenomics 13: 1037-1053
3. Al-Saikhan FI. 2013. The gene therapy revolution in oph- thalmology. Saudi J Ophthalmol 27: 107-111
4. Bora PS, Sohn J-H, Cruz JMC, Jha P, Nishihori H, Wang Y, Kaliappan S, Kaplan HJ, Bora NS. 2005. Role of comple- ment and complement membrane attack complex in la- ser-induced choroidal neovascularization. J Immunol 174: 491-497
5. Boye SE, Boye SL, Lewin AS, Hauswirth WW. 2013. A com- prehensive review of retinal gene therapy. Mol Ther 21: 509-519
6. Braun TA, Mullins RF, Wagner AH, Andorf JL, Johnston RM, Bakall BB, DeLuca AP, Fishman GA, Lam BL, We-leber RG, et al. 2013. Non-exomic and synonymous var- iants in ABCA4 are an important cause of Stargardt dis- ease. Hum Mol Genet 22: 5136-5145
7. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, et al. 2013. Multiplex genome engineering using CRISPR/Cas systems. Science 339: 819-823
8. Curcio CA, Messinger JD, Sloan KR, McGwin G, Medeiros NE, Spaide RF. 2013. Subretinal drusenoid deposits in non-neovascular age-related macular degeneration: Mor- phology, prevalence, topography, and biogenesis model. Retina 33: 265-276
9. Davanger M, Evensen A. 1971. Role of the pericorneal pap- illary structure in renewal of corneal epithelium. Nature 229: 560-561
10. Edwards AO, Ritter R, Abel KJ, Manning A, Panhuysen C, Farrer LA. 2005. Complement factor H polymorphism and age-related macular degeneration. Science 308: 421-424
11. Fritsche LG, Loenhardt T, Janssen A, Fisher SA, Rivera A, Keilhauer CN, Weber BHF. 2008. Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA. Nat Genet 40: 892-896
12. Fritsche LG, Chen W, Schu M, Yaspan BL, Yu Y, Thorleifsson G, Zack DJ, Arakawa S, Cipriani V, Ripke S, et al. 2013. Seven new loci associated with age-related macular de- generation. Nat Genet 45: 433-9-439e1-2
13. Garg SJ, Federman J. 2013. Optogenetics, visual prosthesis and electrostimulation for retinal dystrophies. Curr Opin Ophthalmol 24: 407-414
14. Gass JD. 1973. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol 90: 206-217
15. Gorin MB. 2012. Genetic insights into age-related macular degeneration: Controversies addressing risk, causality, and therapeutics. Mol Aspects Med 33: 467-486
16. Hageman GS, Hancox LS, Taiber AJ, Gehrs KM, Anderson DH, Johnson LV, Radeke MJ, Kavanagh D, Richards A, Atkinson J, et al. 2006. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular de- generation: Characterization, ethnic distribution and evolutionary implications. Ann Med 38: 592-604
17. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, Spencer KL, Kwan SY, Noureddine M, Gilbert JR, et al. 2005. Complement factor H variant increases the risk of age-related macular degeneration. Science 308: 419-421
18. Jager RD, Mieler WF, Miller JW. 2008. Age-related macular degeneration. N Engl J Med 358: 2606-2617
19. Jakobsdottir J, Conley YP, Weeks DE, Mah TS, Ferrell RE, Gorin MB. 2005. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 77: 389-407
20. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, et al. 2002. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418: 41-49
21. Jin Z-B, Okamoto S, Osakada F, Homma K, Assawachana-nont J, Hirami Y, Iwata T, Takahashi M. 2011. Modeling retinal degeneration using patient-specific induced plu- ripotent stem cells. PLoS ONE 6: e17084
22. Johnson LV, Ozaki S, Staples MK, Erickson PA, Anderson DH. 2000. A potential role for immune complex patho-genesis in drusen formation. Exp Eye Res 70: 441-449
23. Johnson LV, Leitner WP, Staples MK, Anderson DH. 2001. Complement activation and inflammatory processes in drusen formation and age related macular degeneration. Exp Eye Res 73: 887-896
24. Joung JK, Sander JD. 2013. TALENs: A widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol 14: 49-55
25. Klein RJ, Zeiss C, Chew EY, Tsai J-Y, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, et al. 2005. Complement factor H polymorphism in age-relat- ed macular degeneration. Science 308: 385-389
26. Liu MM, Chan C-C, Tuo J. 2012. Genetic mechanisms and age-related macular degeneration: Common variants, rare variants, copy number variations, epigenetics, and mitochondrial genetics. Hum Genomics 6: 13
27. Loudin JD, Simanovskii DM, Vijayraghavan K, Sramek CK, Butterwick AF, Huie P, McLean GY, Palanker DV. 2007. Optoelectronic retinal prosthesis: System design and per- formance. J Neural Eng 4: S72-S84
28. McClements ME, MacLaren RE. 2013. Gene therapy for retinal disease. Transl Res 161: 241-254
29. Meyer JS, Howden SE, Wallace KA, Verhoeven AD, Wright LS, Capowski EE, Pinilla I, Martin JM, Tian S, Stewart R, et al. 2011. Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized ap- proach to retinal disease treatment. Stem Cells 29: 1206-1218
30. Mullins RF, Russell SR, Anderson DH, Hageman GS. 2000. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amy- loidosis, and dense deposit disease. FASEB J 14: 835-846
31. Mullins RF, Aptsiauri N, Hageman GS. 2001. Structure and composition of drusen associated with glomerulone- phritis: Implications for the role of complement activa- tion in drusen biogenesis. Eye (Lond) 15: 390-395
32. Mullins RF, Dewald AD, Streb LM, Wang K, Kuehn MH, Stone EM. 2011. Elevated membrane attack complex in human choroid with high risk complement factor H ge- notypes. Exp Eye Res 93: 565-567
33. Packer AM, Roska B, Häusser M. 2013. Targeting neurons and photons for optogenetics. Nat Neurosci 16: 805-815
34. Priya RR, Chew EY, Swaroop A. 2012. Genetic studies of age- related macular degeneration: Lessons, challenges, and opportunities for disease management. Ophthalmology 119: 2526-2536
35. Quazi F, Lenevich S, Molday RS. 2012. ABCA4 is an N-retinylidene-phosphatidylethanolamine and phosphati- dylethanolamine importer. Nat Commun 3: 925
36. Ramsden CM, Powner MB, Carr A-JF, Smart MJK, da Cruz L, Coffey PJ. 2013. Stem cells in retinal regeneration: Past, present and future. Development 140: 2576-2585
37. Rivera A, Fisher SA, Fritsche LG, Keilhauer CN, Lichtner P, Meitinger T, Weber BHF. 2005. Hypothetical LOC387715 is a second major susceptibility gene for age-related mac- ular degeneration, contributing independently of com- plement factor H to disease risk. Hum Mol Genet 14: 3227-3236
38. Ryu E, Fridley BL, Tosakulwong N, Bailey KR, Edwards AO. 2010. Genome-wide association analyses of genetic, phe-notypic, and environmental risks in the age-related eye disease study. Mol Vis 16: 2811-2821
39. Schindler EI, Nylen EL, Ko AC, Affatigato LM, Heggen AC, Wang K, Sheffield VC, Stone EM. 2010. Deducing the pathogenic contribution of recessive ABCA4 alleles in an outbred population. Hum Mol Genet 19: 3693-3701
40. Schwartz SG, Agarwal A, Kovach JL, Gallins PJ, Cade W, Postel EA, Wang G, Ayala-Haedo J, Spencer KM, Haines JL, et al. 2012. The ARMS2 A69S variant and bilateral advanced age-related macular degeneration. Retina 32: 1486-1491
41. Scott AW, Bressler SB. 2013. Long-term follow-up of vascu- lar endothelial growth factor inhibitor therapy for neo-vascular age-related macular degeneration. Curr Opin Ophthalmol 24: 190-196
42. Sheffield VC, Stone EM. 2011. Genomics and the eye. N Engl J Med 364: 1932-1942
43. Shepherd RK, Shivdasani MN, Nayagam DAX, Williams CE, Blamey PJ. 2013. Visual prostheses for the blind. Trends Biotechnol 10: 562-571
44. Singh R, Shen W, Kuai D, Martin JM, Guo X, Smith MA, Perez ET, Phillips MJ, Simonett JM, Wallace KA, et al. 2013. iPS cell modeling of Best disease: Insights into the pathophysiology of an inherited macular degenera- tion. Hum Mol Genet 22: 593-607
45. Snippert HJ, van der Flier LG, Sato T, van Es JH, van den Born M, Kroon-Veenboer C, Barker N, Klein AM, van Rheenen J, Simons BD, et al. 2010. Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell 143: 134-144
46. Swaroop A, Branham KE, Chen W, Abecasis G. 2007. Ge- netic susceptibility to age-related macular degeneration: A paradigm for dissecting complex disease traits. Hum Mol Genet 16: R174-R182
47. Tang PH, Kono M, Koutalos Y, Ablonczy Z, Crouch RK. 2013. New insights into retinoid metabolism and cycling within the retina. Prog Retin Eye Res 32: 48-63
48. Tucker BA, Park I-H, Qi SD, Klassen HJ, Jiang C, Yao J, Redenti S, Daley GQ, Young MJ. 2011a. Transplantation of adult mouse iPS cell-derived photoreceptor precursors restores retinal structure and function in degenerative mice. PLoS ONE 6: e18992
49. Tucker BA, Scheetz TE, Mullins RF, DeLuca AP, Hoff- mann JM, Johnston RM, Jacobson SG, Sheffield VC, Stone EM. 2011b. Exome sequencing and analysis of induced pluripotent stem cells identify the cilia-relat- ed gene male germ cell-associated kinase (MAK) as a cause of retinitis pigmentosa. Proc Natl Acad Sci 108: E569-E576
50. Tucker BA, Anfinson KR, Mullins RF, Stone EM, Young MJ. 2013a. Use of a synthetic xeno-free culture substrate for induced pluripotent stem cell induction and retinal dif- ferentiation. Stem Cells Transl Med 2: 16-24
51. Tucker BA, Mullins RF, Streb LM, Anfinson K, Eyestone ME, Kaalberg E, Riker MJ, Drack AV, Braun TA, Stone EM. 2013b. Patient-specific iPSC-derived photoreceptor pre- cursor cells as a means to investigate retinitis pigmentosa. eLife 2: e00824
52. Wang S, Girman S, Lu B, Bischoff N, Holmes T, Shearer R, Wright LS, Svendsen CN, Gamm DM, Lund RD. 2008. Long-term vision rescue by human neural progenitors in a rat model of photoreceptor degeneration. Invest Oph- thalmol Vis Sci 49: 3201-3206
53. Yamanaka S, Takahashi K. 2006. Induction of pluripotent stem cells from mouse fibroblast cultures. Tanpakushitsu Kakusan Koso 51: 2346-2351
54. Yang J, Li Y, Chan L, Tsai Y-T, Wu W-H, Nguyen HV, Hsu C- W, Li X, Brown LM, Egli D, et al. 2014. Validation of genome-wide association study (GWAS)-identified dis- ease risk alleles with patient-specific stem cell lines. Hum Mol Genet 23: 3445-3455
55. Yao J, Tucker BA, Zhang X, Checa-Casalengua P, Herrero- Vanrell R, Young MJ. 2011. Robust cell integration from co-transplantation of biodegradable MMP2-PLGA mi- crospheres with retinal progenitor cells. Biomaterials 32: 1041-1050
56. Yonehara K, Farrow K, Ghanem A, Hillier D, Balint K, Teix- eira M, Juttner J, Noda M, Neve RL, Conzelmann K-K, et al. 2013. The first stage of cardinal direction selectivity is localized to the dendrites of retinal ganglion cells. Neuron 79: 1078-1085
57. Zareparsi S, Branham KEH, Li M, Shah S, Klein RJ, Ott J, Hoh J, Abecasis GR, Swaroop A. 2005. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet 77: 149-153
58. Zhang Y, Klassen HJ, Tucker BA, Perez M-TR, Young MJ. 2007. CNS progenitor cells promote a permissive envi-ronment for neurite outgrowth via a matrix metallopro- teinase-2-dependent mechanism. J Neurosci 27: 4499-4506
59. Zhang H, Morrison MA, Dewan A, Adams S, Andreoli M, Huynh N, Regan M, Brown A, Miller JW, Kim IK, et al. 2008. The NEI/NCBI dbGAP database: Genotypes and haplotypes that may specifically predispose to risk of neo- vascular age-related macular degeneration. BMC Med Genet 9: 51
60. Zrenner E, Bartz-Schmidt KU, Benav H, Besch D, Bruck- mann A, Gabel V-P, Gekeler F, Greppmaier U, Harscher A, Kibbel S, et al. 2011. Subretinal electronic chips allow blind patients to read letters and combine them to words. Proc Biol Sci 278: 1489-1497